Literature DB >> 12451619

Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.

Donato Nitti1, Claudio Belluco, Enzo Mammano, Alberto Marchet, Alessandro Ambrosi, Roberto Mencarelli, Paola Segato, Mario Lise.   

Abstract

BACKGROUND AND OBJECTIVES: Low tumor expression of the p27(Kip1) protein, which is involved in cell cycle control and apoptosis, is considered a negative prognostic factor in different types of cancer. The aim of this study was to evaluate the clinical and pathological significance of low p27(Kip1) protein expression in patients who had undergone resection for gastric adenocarcinoma.
METHODS: p27(Kip1) protein was studied by immunohistochemistry in formalin-fixed tumor sections from 95 patients who underwent resection for gastric adenocarcinoma between 1991 and 1996. Based on the median value of protein expression, p27(Kip1) protein expression was classified as low or high.
RESULTS: Low p27(Kip1) protein expression was significantly associated with tumor de-differentiation, increased penetration through the gastric wall, lymph node metastasis, and advanced tumor stage. In the group of 84 patients who underwent curative surgery, 5-year survival was 74% in cases with high p27(Kip1) protein expression and 38% in those with low p27(Kip1) protein expression (P < 0.001). At multivariate analysis, low p27(Kip1) protein expression was an independent negative prognostic factor for survival (RR = 3.671; P = 0.004).
CONCLUSIONS: In gastric adenocarcinoma, low p27(Kip1) protein expression is associated with poorly differentiated and advanced tumors and is a negative prognostic factor of potential clinical value. Copyright 2002 Wiley-Liss. Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451619     DOI: 10.1002/jso.10172

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  17 in total

1.  Effect of p27(KIP1) on cell cycle and apoptosis in gastric cancer cells.

Authors:  Jian-Yong Zheng; Wei-Zhong Wang; Kai-Zong Li; Wen-Xian Guan; Wei Yan
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Characterization of oncogene suppressor marker expression in patients with submucosal gastric carcinoma.

Authors:  Roberson A Moron; Carlos Eduardo Jacob; Claudio José Caldas Bresciani; Kleber Simões; Venâncio Avancini Ferreira Alves; Kyoshi Irya; Joaquim Gama-Rodrigues; Ivan Cecconello; Adhemar Longatto-Filho; Bruno Zilberstein
Journal:  Mol Clin Oncol       Date:  2017-12-29

3.  Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.

Authors:  Zhao Jing; Ke-Jun Nan; Mei-Long Hu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

Review 4.  Genomic and genetic alterations influence the progression of gastric cancer.

Authors:  Stefania Nobili; Lorenzo Bruno; Ida Landini; Cristina Napoli; Paolo Bechi; Francesco Tonelli; Carlos A Rubio; Enrico Mini; Gabriella Nesi
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

5.  Expression and hypermethylation of p27 kip1 in hepatocarcinogenesis.

Authors:  Pu-Ping Lei; Zong-Ji Zhang; Li-Juan Shen; Jin-Yun Li; Qiong Zou; Hua-Xian Zhang
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

6.  Molecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro.

Authors:  Jin-Shui Zhu; Bo Shen; Jin-Lian Chen; Guo-Qiang Chen; Xiao-Hu Yu; Hua-Fang Yu; Zu-Ming Zhu
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.

Authors:  Armando Gamboa-Dominguez; Stefan Seidl; Edgardo Reyes-Gutierrez; Christine Hermannstädter; Leticia Quintanilla-Martinez; Raymonde Busch; Heinz Höfler; Falko Fend; Birgit Luber
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

8.  Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.

Authors:  Ke-Jun Nan; Zhao Jing; Ling Gong
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

9.  Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).

Authors:  Ziliang Jin; Weihua Jiang; Liwei Wang
Journal:  Oncol Lett       Date:  2015-02-12       Impact factor: 2.967

10.  BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.

Authors:  Y Hirata; N Ogasawara; M Sasaki; T Mizushima; T Shimura; T Mizoshita; Y Mori; E Kubota; T Wada; S Tanida; H Kataoka; T Kamiya; S Higashiyama; T Joh
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.